ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > IL-1 alpha

IL-1 alpha

概要

Name:Interleukin-1 alpha
Target Synonym:Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

ILA-H5214-SPR
 IL-1 alpha SPR

Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) immobilized on CM5 Chip can bind Human IL-1 alpha Protein, premium grade (Cat. No. ILA-H5214) with an affinity constant of 18.8 μM as determined in a SPR assay (Biacore 8K) (QC tested).

ILA-H5216-ELISA
 IL-1 alpha ELISA

Immobilized Human IL-1 RI Protein, Fc Tag (Cat. No. ILI-H5253) at 10 μg/mL (100 μL/well) can bind Human IL-1 alpha, His Tag (Cat. No. ILA-H5216) with a linear range of 0.3-2.5 μg/mL (QC tested).

Synonym Name

IL1A,IL-1 ALPHA,IL1F1,IL1α

Background

Interleukin-1 alpha (IL1a) is also known as  IL-1A, IL1, IL1-ALPHA,IL1F1,and is a cytokine of the interleukin-1 family. IL1a possesses a wide spectrum of metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. It binds to the interleukin-1 receptor. IL-1α is constitutively produced by epithelial cells. It is found in substantial amounts in normal human epidermis and is distributed in a 1:1 ratio between living epidermal cells and stratum corneum.The constitutive production of large amounts of IL-1α precursor by healthy epidermal keratinocytes interfere with the important role of IL-1α in immune responses, assuming skin as a barrier, which prevents the entry of pathogenic microorganisms into the body. In vitro, IL-1α possesses biological effect on cells in the picomolar to femtomolar range. In vivo, Shortly after an onset of an infection into organism, IL-1α activates a set of immune system response processes.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Rilonacept KPL-914; RGN-303 Approved Regeneron Pharmaceuticals Inc Arcalyst United States Cryopyrin-Associated Periodic Syndromes Kiniksa Pharmaceuticals Ltd 2008-02-27 Genetic Diseases, Inborn; Renal Insufficiency, Chronic; Inflammation; Gout; Scleroderma, Diffuse; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Pericarditis; Still's Disease, Adult-Onset; Arthritis, Juvenile; Deficiency of interleukin-1 receptor antagonist; Muckle-Wells Syndrome (MWS); Scleroderma, Systemic; Schnitzler Syndrome; Anemia; Diabetes Mellitus, Type 1; Familial Mediterranean Fever Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
AC-701 AC-701 Phase 2 Clinical Twi Pharmaceuticals Inc Rosacea; Exanthema Details
lutikizumab ABT-981 Phase 2 Clinical Abbvie Inc Osteoarthritis, Knee; Hidradenitis Suppurativa; Osteoarthritis Details
CAN-10 CAN-10 Phase 1 Clinical Lund University Foundation Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis Details
Bermekimab T2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1 Phase 2 Clinical Xbiotech Inc Acne Vulgaris; Hematologic Neoplasms; Pyoderma Gangrenosum; Digestive System Diseases; Diabetes Mellitus, Type 2; Neoplasms; Scleroderma, Systemic; Psoriasis; Colorectal Neoplasms; Hidradenitis Suppurativa; Eczema; Dermatitis, Atopic Details
Vilamakitug XB-2001 Phase 2 Clinical Xbiotech Inc Pancreatic Neoplasms; Arthritis, Rheumatoid; Rheumatic Diseases Details
Tadekinig alfa (AB2 Bio) Phase 3 Clinical Ab2 Bio Ltd Macrophage Activation Syndrome; Cytokine Release Syndrome; Lymphohistiocytosis, Hemophagocytic Details
Hutrukin Phase 1 Clinical Xbiotech Inc Details

This web search service is supported by Google Inc.

totopphone